Legend Biotech Ownership 2024 | Who Owns Legend Biotech Now?
Institutional Ownership
49.17%
Insider Ownership
1.32%
Retail Ownership
49.51%
Institutional Holders
210.00
Legend Biotech Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 9.17% | 0.06% | 16,147,032 | 3,349,038 | 26.17% | 905,687,025 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.22% | 0.08% | 10,949,120 | 140,904 | 1.30% | 614,137,000 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 3.90% | 0.56% | 6,861,097 | 596,390 | 9.52% | 384,838,931 | Mar 31, 2024 |
| HHLR ADVISORS, LTD. | 3.40% | 7.29% | 5,984,550 | - | - | 335,673,410 | Mar 31, 2024 |
| BLACKROCK INC. | 3.06% | 0.01% | 5,384,030 | 117,842 | 2.24% | 301,990,242 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.48% | 0.03% | 2,614,423 | 308,032 | 13.36% | 146,642,986 | Mar 31, 2024 |
| CAPITAL WORLD INVESTORS | 1.35% | 0.02% | 2,385,960 | - | - | 133,828,496 | Mar 31, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.27% | 0.66% | 2,239,774 | 463,527 | 26.10% | 125,628,902 | Mar 31, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 1.24% | 0.02% | 2,181,074 | 356,387 | 19.53% | 122,336,441 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 1.14% | 0.06% | 2,014,012 | 148,855 | 7.98% | 112,982,038 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.13% | 3.91% | 1,982,006 | 87,362 | 4.61% | 111,170,717 | Mar 31, 2024 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1.07% | 0.03% | 1,890,796 | -94,030 | -4.74% | 106,054,748 | Mar 31, 2024 |
| FEDERATED HERMES, INC. | 0.87% | 0.20% | 1,537,060 | -188,912 | -10.95% | 86,213,695 | Mar 31, 2024 |
| BRAIDWELL LP | 0.71% | 2.25% | 1,243,795 | 681,195 | 121.08% | 69,764,462 | Mar 31, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.66% | 0.94% | 1,158,500 | 92,611 | 8.69% | 64,980,000 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.65% | 0.01% | 1,144,476 | 978,545 | 589.73% | 64,193,659 | Mar 31, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.63% | 0.02% | 1,113,158 | -72,799 | -6.14% | 62,437,032 | Mar 31, 2024 |
| STATE STREET CORP | 0.60% | 0.00% | 1,048,002 | 11,257 | 1.09% | 58,782,432 | Mar 31, 2024 |
| ARROWMARK COLORADO HOLDINGS LLC | 0.59% | 0.66% | 1,046,739 | -17,803 | -1.67% | 58,711,591 | Mar 31, 2024 |
| JOHNSON & JOHNSON | 0.46% | 1.04% | 814,586 | - | - | 45,690,129 | Mar 31, 2024 |
Legend Biotech's largest institutional shareholder is FMR LLC, holding 9.17% of the company's total share outstanding, currently valued at $905.69M. The top 10 institutional shareholders own together 32.24% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALTITUDE CREST PARTNERS INC. | 0.37% | 15.67% | 652,732 | 110,916 | 20.47% | 36,611,738 | Mar 31, 2024 |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 0.43% | 8.31% | 751,935 | -57,639 | -7.12% | 42,176,034 | Mar 31, 2024 |
| HHLR ADVISORS, LTD. | 3.40% | 7.29% | 5,984,550 | - | - | 335,673,410 | Mar 31, 2024 |
| TRI LOCUM PARTNERS LP | 0.16% | 5.52% | 283,773 | 181,558 | 177.62% | 15,916,828 | Mar 31, 2024 |
| PARADIGM BIOCAPITAL ADVISORS LP | 1.13% | 3.91% | 1,982,006 | 87,362 | 4.61% | 111,170,717 | Mar 31, 2024 |
| BRAIDWELL LP | 0.71% | 2.25% | 1,243,795 | 681,195 | 121.08% | 69,764,462 | Mar 31, 2024 |
| OLD WELL PARTNERS, LLC | 0.02% | 2.10% | 42,001 | - | - | 2,355,836 | Mar 31, 2024 |
| E FUND MANAGEMENT (HONG KONG) CO., LTD. | 0.03% | 2.10% | 57,052 | -6,845 | -10.71% | 3,200,000 | Mar 31, 2024 |
| PFM HEALTH SCIENCES, LP | 0.42% | 1.94% | 734,293 | 55,217 | 8.13% | 41,186,494 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.13% | 1.92% | 228,251 | -247,828 | -52.06% | 12,802,599 | Mar 31, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.05% | 1.73% | 79,830 | 79,830 | 100.00% | 4,477,665 | Mar 31, 2024 |
| BOXER CAPITAL, LLC | 0.34% | 1.66% | 600,000 | - | - | 33,654,000 | Mar 31, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.38% | 1.21% | 668,300 | -16,700 | -2.44% | 37,484,947 | Mar 31, 2024 |
| ARDSLEY ADVISORY PARTNERS LP | 0.08% | 1.13% | 140,000 | 55,000 | 64.71% | 7,852,600 | Mar 31, 2024 |
| JOHNSON & JOHNSON | 0.46% | 1.04% | 814,586 | - | - | 45,690,129 | Mar 31, 2024 |
| PARAMETRICA MANAGEMENT LTD | 0.01% | 0.95% | 11,800 | - | - | 661,862 | Mar 31, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.66% | 0.94% | 1,158,500 | 92,611 | 8.69% | 64,980,000 | Mar 31, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.02% | 0.73% | 36,385 | -7,920 | -17.88% | 2,040,835 | Mar 31, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 0.28% | 0.71% | 499,486 | 7,042 | 1.43% | 28,016,170 | Mar 31, 2024 |
| EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. | 0.04% | 0.67% | 69,259 | 9,001 | 14.94% | 3,886,815 | Mar 31, 2024 |
The largest Legend Biotech shareholder by % of total assets is ALTITUDE CREST PARTNERS INC.. The company owns 652.73K shares of Legend Biotech (LEGN), representing 15.67% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 9.17% | 0.06% | 16,147,032 | 3,349,038 | 26.17% | 905,687,025 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.65% | 0.01% | 1,144,476 | 978,545 | 589.73% | 64,193,659 | Mar 31, 2024 |
| BRAIDWELL LP | 0.71% | 2.25% | 1,243,795 | 681,195 | 121.08% | 69,764,462 | Mar 31, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 3.90% | 0.56% | 6,861,097 | 596,390 | 9.52% | 384,838,931 | Mar 31, 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.27% | 0.66% | 2,239,774 | 463,527 | 26.10% | 125,628,902 | Mar 31, 2024 |
| CAPITAL INTERNATIONAL INVESTORS | 1.24% | 0.02% | 2,181,074 | 356,387 | 19.53% | 122,336,441 | Mar 31, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.48% | 0.03% | 2,614,423 | 308,032 | 13.36% | 146,642,986 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.17% | 0.00% | 307,900 | 307,900 | 100.00% | 17,270,111 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 0.00% | 228,700 | 228,700 | 100.00% | 12,827,783 | Mar 31, 2024 |
| TRI LOCUM PARTNERS LP | 0.16% | 5.52% | 283,773 | 181,558 | 177.62% | 15,916,828 | Mar 31, 2024 |
| JANUS HENDERSON GROUP PLC | 1.14% | 0.06% | 2,014,012 | 148,855 | 7.98% | 112,982,038 | Mar 31, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6.22% | 0.08% | 10,949,120 | 140,904 | 1.30% | 614,137,000 | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0.07% | 0.25% | 130,000 | 130,000 | 100.00% | 7,291,700 | Mar 31, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.07% | 0.01% | 118,845 | 118,845 | 100.00% | 6,666,000 | Mar 31, 2024 |
| BLACKROCK INC. | 3.06% | 0.01% | 5,384,030 | 117,842 | 2.24% | 301,990,242 | Mar 31, 2024 |
| DUQUESNE FAMILY OFFICE LLC | 0.07% | 0.15% | 114,500 | 114,500 | 100.00% | 6,422,000 | Mar 31, 2024 |
| ALTITUDE CREST PARTNERS INC. | 0.37% | 15.67% | 652,732 | 110,916 | 20.47% | 36,611,738 | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0.06% | 0.19% | 100,000 | 100,000 | 100.00% | 5,609,000 | Mar 31, 2024 |
| BAMCO INC /NY/ | 0.16% | 0.04% | 276,827 | 97,259 | 54.16% | 15,527,226 | Mar 31, 2024 |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 0.66% | 0.94% | 1,158,500 | 92,611 | 8.69% | 64,980,000 | Mar 31, 2024 |
As of Mar 31 2024, Legend Biotech's largest institutional buyer is FMR LLC. The company purchased 3.35M stocks of LEGN, valued at $905.69M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| POLAR CAPITAL HOLDINGS PLC | 0.09% | 0.05% | 156,075 | -1,214,401 | -88.61% | 8,754,247 | Mar 31, 2024 |
| HOLOCENE ADVISORS, LP | 0.43% | 0.16% | 761,626 | -999,071 | -56.74% | 42,719,602 | Mar 31, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -615,000 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | 0.19% | 0.00% | 342,033 | -548,454 | -61.59% | 19,184,634 | Mar 31, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -457,490 | -100.00% | - | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -417,100 | -100.00% | - | Mar 31, 2024 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -380,000 | -100.00% | - | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0.13% | 0.45% | 235,493 | -330,530 | -58.40% | 13,208,802 | Mar 31, 2024 |
| FIRST TURN MANAGEMENT, LLC | 0.13% | 1.92% | 228,251 | -247,828 | -52.06% | 12,802,599 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -234,206 | -100.00% | - | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.18% | 0.00% | 310,408 | -212,259 | -40.61% | 17,410,785 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.21% | 0.01% | 371,091 | -211,059 | -36.26% | 20,814,494 | Mar 31, 2024 |
| FEDERATED HERMES, INC. | 0.87% | 0.20% | 1,537,060 | -188,912 | -10.95% | 86,213,695 | Mar 31, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 0.01% | 0.00% | 16,284 | -185,852 | -91.94% | 913,370 | Mar 31, 2024 |
| UBS GROUP AG | 0.07% | 0.00% | 128,116 | -171,127 | -57.19% | 7,186,027 | Mar 31, 2024 |
| D. E. SHAW & CO., INC. | 0.02% | 0.00% | 40,922 | -129,207 | -75.95% | 2,295,315 | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -122,000 | -100.00% | - | Mar 31, 2024 |
| BRIDGEWATER ASSOCIATES, LP | 0.12% | 0.06% | 208,900 | -121,191 | -36.71% | 11,717,201 | Mar 31, 2024 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | - | - | - | -110,113 | -100.00% | - | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -104,650 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Legend Biotech's biggest institutional seller is POLAR CAPITAL HOLDINGS PLC. The company sold -1.21M shares of LEGN, valued at $8.75M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.17% | 0.00% | 307,900 | 307,900 | 100.00% | 17,270,111 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.13% | 0.00% | 228,700 | 228,700 | 100.00% | 12,827,783 | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0.07% | 0.25% | 130,000 | 130,000 | 100.00% | 7,291,700 | Mar 31, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 0.07% | 0.01% | 118,845 | 118,845 | 100.00% | 6,666,000 | Mar 31, 2024 |
| DUQUESNE FAMILY OFFICE LLC | 0.07% | 0.15% | 114,500 | 114,500 | 100.00% | 6,422,000 | Mar 31, 2024 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0.06% | 0.19% | 100,000 | 100,000 | 100.00% | 5,609,000 | Mar 31, 2024 |
| DECHENG CAPITAL LLC | 0.05% | 0.65% | 86,363 | 86,363 | 100.00% | 4,844,101 | Mar 31, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | 0.05% | 1.73% | 79,830 | 79,830 | 100.00% | 4,477,665 | Mar 31, 2024 |
| KEYSTONE INVESTORS PTE LTD | 0.02% | 0.17% | 35,885 | 35,885 | 100.00% | 2,012,790 | Mar 31, 2024 |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 0.02% | 0.09% | 34,746 | 34,746 | 100.00% | 1,948,903 | Mar 31, 2024 |
| GROUPAMA ASSET MANAGMENT | 0.01% | 0.02% | 21,422 | 21,422 | 100.00% | 1,201,560 | Mar 31, 2024 |
| NORDEA INVESTMENT MANAGEMENT AB | 0.01% | 0.00% | 14,987 | 14,987 | 100.00% | 842,569 | Mar 31, 2024 |
| BARCLAYS PLC | 0.01% | 0.00% | 14,200 | 14,200 | 100.00% | 796,000 | Mar 31, 2024 |
| HRT FINANCIAL LP | 0.01% | 0.00% | 9,959 | 9,959 | 100.00% | 558,000 | Mar 31, 2024 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.00% | 0.00% | 4,827 | 4,827 | 100.00% | 271,000 | Mar 31, 2024 |
| DNB ASSET MANAGEMENT AS | 0.00% | 0.00% | 4,589 | 4,589 | 100.00% | 257,397 | Mar 31, 2024 |
| Y-INTERCEPT (HONG KONG) LTD | 0.00% | 0.02% | 4,570 | 4,570 | 100.00% | 256,331 | Mar 31, 2024 |
| INTECH INVESTMENT MANAGEMENT LLC | 0.00% | 0.00% | 4,226 | 4,226 | 100.00% | 237,036 | Mar 31, 2024 |
| NOMURA HOLDINGS INC | 0.00% | 0.00% | 3,657 | 3,657 | 100.00% | 205,121 | Mar 31, 2024 |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 0.00% | 0.00% | 3,617 | 3,617 | 100.00% | 203,000 | Mar 31, 2024 |
| BNP PARIBAS | 0.00% | 0.01% | 3,556 | 3,556 | 100.00% | 199,456 | Mar 31, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.00% | 0.00% | 3,000 | 3,000 | 100.00% | 171,660,000 | Mar 31, 2024 |
| DEGROOF PETERCAM ASSET MANAGEMENT | 0.00% | 0.00% | 2,600 | 2,600 | 100.00% | 145,834 | Mar 31, 2024 |
| WALLEYE CAPITAL LLC | 0.00% | 0.00% | 2,216 | 2,216 | 100.00% | 124,295 | Mar 31, 2024 |
| CUTLER GROUP LLC / CA | 0.00% | 0.03% | 1,900 | 1,900 | 100.00% | 106,000 | Mar 31, 2024 |
| ENTRYPOINT CAPITAL, LLC | 0.00% | 0.01% | 176 | 176 | 100.00% | 9,872 | Mar 31, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | 0.00% | 51 | 51 | 100.00% | 2,918,000 | Mar 31, 2024 |
Legend Biotech's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 307.90K shares, valued at $17.27M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -615,000 | -100.00% | - | Mar 31, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | - | - | - | -457,490 | -100.00% | - | Mar 31, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | - | - | - | -417,100 | -100.00% | - | Mar 31, 2024 |
| IRON TRIANGLE PARTNERS LP | - | - | - | -380,000 | -100.00% | - | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -234,206 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -122,000 | -100.00% | - | Mar 31, 2024 |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | - | - | - | -110,113 | -100.00% | - | Mar 31, 2024 |
| STEMPOINT CAPITAL LP | - | - | - | -104,650 | -100.00% | - | Mar 31, 2024 |
| ANDRA AP-FONDEN | - | - | - | -63,600 | -100.00% | - | Mar 31, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -50,000 | -100.00% | - | Mar 31, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -37,900 | -100.00% | - | Mar 31, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -35,800 | -100.00% | - | Mar 31, 2024 |
| TREXQUANT INVESTMENT LP | - | - | - | -25,949 | -100.00% | - | Mar 31, 2024 |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | - | - | - | -14,595 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA ADVISERS, LP | - | - | - | -14,400 | -100.00% | - | Mar 31, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -13,009 | -100.00% | - | Mar 31, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -10,906 | -100.00% | - | Mar 31, 2024 |
| BOSTON PARTNERS | - | - | - | -10,196 | -100.00% | - | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -7,396 | -100.00% | - | Mar 31, 2024 |
| WEXFORD CAPITAL LP | - | - | - | -7,062 | -100.00% | - | Mar 31, 2024 |
| NEUBERGER BERMAN GROUP LLC | - | - | - | -6,244 | -100.00% | - | Mar 31, 2024 |
| POLYMER CAPITAL MANAGEMENT (HK) LTD | - | - | - | -5,000 | -100.00% | - | Mar 31, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | - | - | - | -4,960 | -100.00% | - | Mar 31, 2024 |
| EFG ASSET MANAGEMENT (AMERICAS) CORP. | - | - | - | -4,641 | -100.00% | - | Mar 31, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -4,599 | -100.00% | - | Mar 31, 2024 |
| LORD, ABBETT & CO. LLC | - | - | - | -3,385 | -100.00% | - | Mar 31, 2024 |
| WALLEYE TRADING LLC | - | - | - | -2,900 | -100.00% | - | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | - | - | - | -2,560 | -100.00% | - | Mar 31, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -2,500 | -100.00% | - | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -1,752 | -100.00% | - | Mar 31, 2024 |
| IA GLOBAL ASSET MANAGEMENT INC. | - | - | - | -1,519 | -100.00% | - | Mar 31, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -1,000 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -704 | -100.00% | - | Mar 31, 2024 |
| PEAK6 INVESTMENTS LLC | - | - | - | -704 | -100.00% | - | Mar 31, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -275 | -100.00% | - | Mar 31, 2024 |
| GLASSMAN WEALTH SERVICES | - | - | - | -234 | -100.00% | - | Mar 31, 2024 |
| ASSETMARK, INC | - | - | - | -18 | -100.00% | - | Mar 31, 2024 |
Legend Biotech's largest sold out institutional shareholder by shares sold is ADAGE CAPITAL PARTNERS GP, L.L.C., sold -0.61M shares, valued at -, as of undefined.
Legend Biotech Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| AMG FUNDS | 2.57% | 287,292 | - | - | Jan 31, 2024 |
| MFS SERIES TRUST IV | 0.39% | 1,339,933 | -4,598 | -0.34% | Feb 29, 2024 |
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.34% | 316,221 | - | - | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.28% | 1,371,683 | -173,226 | -11.21% | Dec 31, 2023 |
| Clough Global Equity Fund | 0.20% | 12,300 | - | - | Jan 31, 2024 |
| Tema ETF Trust | 0.16% | 6,978 | 2,278 | 48.47% | Feb 29, 2024 |
| T. Rowe Price Growth Stock Fund, Inc. | 0.15% | 2,066,141 | 366,300 | 21.55% | Dec 31, 2023 |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. | 0.15% | 80,600 | 16,800 | 26.33% | Dec 31, 2023 |
| AB DISCOVERY GROWTH FUND, INC. | 0.15% | 217,687 | 16,435 | 8.17% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.14% | 1,200,000 | 200,000 | 20.00% | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.12% | 316,032 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.11% | 3,030,177 | -127,249 | -4.03% | Feb 29, 2024 |
| MERIDIAN FUND INC | 0.10% | 355,015 | -6,475 | -1.79% | Dec 29, 2023 |
| Clough Funds Trust | 0.09% | 3,716 | - | - | Jan 31, 2023 |
| BlackRock Health Sciences Trust | 0.08% | 32,098 | - | - | Dec 31, 2023 |
| T. Rowe Price Equity Funds, Inc. | 0.07% | 1,250,809 | 152,800 | 13.92% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.07% | 187,500 | -57,500 | -23.47% | Dec 31, 2023 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.07% | 42,997 | - | - | Feb 29, 2024 |
| Clough Global Opportunities Fund | 0.06% | 22,700 | - | - | Jan 31, 2024 |
| LORD ABBETT RESEARCH FUND INC | 0.06% | 53,910 | - | - | Feb 29, 2024 |
| SMALLCAP WORLD FUND INC | 0.05% | 3,148,299 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.04% | 2,870,010 | 694,300 | 31.91% | Feb 29, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.04% | 62,937 | -8,946 | -12.45% | Dec 31, 2023 |
| T. Rowe Price Tax-Efficient Funds, Inc. | 0.03% | 3,200 | 700 | 28.00% | Feb 29, 2024 |
| RENAISSANCE CAPITAL GREENWICH FUNDS | 0.03% | 18,300 | - | - | Dec 31, 2023 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.03% | 59,143 | - | - | Feb 29, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.03% | 53,600 | -81,200 | -60.24% | Dec 31, 2023 |
| T. Rowe Price New Horizons Fund, Inc. | 0.03% | 389,930 | -1,300 | -0.33% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND III | 0.02% | 204,440 | -65,400 | -24.24% | Dec 31, 2023 |
| Fidelity Central Investment Portfolios LLC | 0.02% | 407,286 | - | - | Feb 29, 2024 |
| OBERWEIS FUNDS | 0.02% | 16,000 | - | - | Dec 31, 2023 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 0.02% | 58,927 | - | - | Dec 31, 2023 |
| ALGER FUNDS | 0.01% | 14,296 | - | - | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.01% | 157,900 | 1,000 | 0.64% | Jan 31, 2024 |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0.01% | 97,500 | 20,000 | 25.81% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.01% | 265,300 | -20,000 | -7.01% | Dec 31, 2023 |
| ALPS ETF Trust | 0.01% | 174,194 | - | - | Feb 29, 2024 |
| EMERGING MARKETS GROWTH FUND INC | 0.01% | 188,351 | -6,837 | -3.50% | Dec 31, 2023 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 105,093 | 11,819 | 12.67% | Dec 29, 2023 |
| FIDELITY CONTRAFUND | 0.01% | 853,348 | -772,586 | -47.52% | Dec 31, 2023 |
| Humankind Benefit Corp | 0.01% | 230 | - | - | Dec 31, 2023 |
| MFS SERIES TRUST I | 0.01% | 171,060 | - | - | Feb 29, 2024 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 0.01% | 57,861 | - | - | Dec 31, 2023 |
| RYDEX SERIES FUNDS | 0.01% | 28,526 | 28,526 | - | Dec 31, 2023 |
| BARON SELECT FUNDS | 0.01% | 75,000 | -4,700 | -5.90% | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.01% | 84,239 | -59,307 | -41.32% | Dec 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 19,970 | 310 | 1.58% | Feb 29, 2024 |
| Gabelli Healthcare & WellnessRx Trust | 0.01% | 720 | - | - | Dec 29, 2023 |
| FIDELITY PURITAN TRUST | 0.01% | 297,508 | -472,525 | -61.36% | Feb 29, 2024 |
| FIDELITY SECURITIES FUND | 0.01% | 509,497 | 509,497 | - | Jan 31, 2024 |
| TOUCHSTONE STRATEGIC TRUST | 0.01% | 287,341 | 82,574 | 40.33% | Dec 31, 2023 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 21,643 | - | - | Dec 31, 2023 |
| HOMESTEAD FUNDS INC | 0.00% | 22,217 | 3,625 | 19.50% | Dec 31, 2023 |
| ETFis Series Trust I | 0.00% | 5,314 | 905 | 20.53% | Jan 31, 2024 |
| FIDELITY INVESTMENT TRUST | 0.00% | 734,227 | 255,044 | 53.22% | Jan 31, 2024 |
| Bernstein Fund Inc | 0.00% | 31,810 | - | - | Dec 31, 2023 |
| JANUS INVESTMENT FUND | 0.00% | 841,640 | 14,791 | 1.79% | Dec 31, 2023 |
| MFS VARIABLE INSURANCE TRUST | 0.00% | 84,286 | 1,693 | 2.05% | Dec 31, 2023 |
| RYDEX VARIABLE TRUST | 0.00% | 3,102 | 3,102 | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 23,554 | -29,955 | -55.98% | Dec 31, 2023 |
| FIDELITY ADVISOR SERIES I | 0.00% | 330,877 | 295,977 | 848.07% | Feb 29, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 23,259 | 12,200 | 110.32% | Feb 29, 2024 |
| AMERICAN FUNDS DEVELOPING WORLD GROWTH & INCOME FUND | 0.00% | 41,654 | -6,083 | -12.74% | Feb 29, 2024 |
| LORD ABBETT BOND DEBENTURE FUND INC | 0.00% | 426,613 | - | - | Dec 31, 2023 |
| Harbor ETF Trust | 0.00% | 7,479 | 2,852 | 61.64% | Jan 31, 2024 |
| Forethought Variable Insurance Trust | 0.00% | 6,300 | - | - | Dec 29, 2023 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 3,151 | - | - | Mar 31, 2024 |
| Voya PARTNERS INC | 0.00% | 105,072 | 15,600 | 17.44% | Dec 31, 2023 |
| Krane Shares Trust | 0.00% | 19,628 | 362 | 1.88% | Dec 31, 2023 |
| AB VARIABLE PRODUCTS SERIES FUND, INC. | 0.00% | 5,020 | -740 | -12.85% | Mar 31, 2024 |
| T. Rowe Price Exchange-Traded Funds, Inc. | 0.00% | 6,116 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 14,228 | - | - | Jan 31, 2024 |
| BlackRock ETF Trust | 0.00% | 814 | 29 | 3.69% | Jan 31, 2024 |
| ALLSPRING VARIABLE TRUST | 0.00% | 398 | - | - | Dec 31, 2023 |
| UBS FUNDS | 0.00% | 3,200 | - | - | Dec 31, 2023 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,980 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 780,108 | 264,849 | 51.40% | Feb 29, 2024 |
| AdvisorShares Trust | 0.00% | 1,725 | - | - | Dec 29, 2023 |
| SEASONS SERIES TRUST | 0.00% | 13,909 | 2,550 | 22.45% | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 15,249 | 4,289 | 39.13% | Dec 29, 2023 |
| BLACKROCK SUSTAINABLE BALANCED FUND, INC. | 0.00% | 3,792 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.00% | 3,734 | - | - | Jan 31, 2024 |
| MATTHEWS INTERNATIONAL FUNDS | 0.00% | 9,493 | -857,697 | -98.91% | Dec 31, 2023 |
| OLD WESTBURY FUNDS INC | 0.00% | 65,834 | -12,044 | -15.47% | Jan 31, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 92,841 | 115 | 0.12% | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 9,118 | 1,051 | 13.03% | Dec 31, 2023 |
| PRINCIPAL VARIABLE CONTRACTS FUNDS INC | 0.00% | 17,211 | 2,990 | 21.03% | Dec 31, 2023 |
| Brinker Capital Destinations Trust | 0.00% | 22,869 | - | - | Feb 29, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 321,308 | -21,806 | -6.36% | Dec 31, 2023 |
| Virtus Strategy Trust | 0.00% | 7,276 | - | - | Dec 29, 2023 |
| LORD ABBETT SERIES FUND INC | 0.00% | 7,498 | - | - | Dec 31, 2023 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 1,160 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,100 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 20,600 | 2,100 | 11.35% | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 46,908 | - | - | Feb 29, 2024 |
| T. Rowe Price Spectrum Funds II, Inc. | 0.00% | 2,995 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 60,754 | -7,467 | -10.95% | Jan 31, 2024 |
| HARBOR FUNDS | 0.00% | 4,442 | -55 | -1.22% | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 222,468 | -820 | -0.37% | Dec 31, 2023 |
| Franklin Custodian Funds | 0.00% | 100,000 | - | - | Dec 31, 2023 |
Legend Biotech's largest mutual fund holder by % of total assets is "AMG FUNDS", owning 287.29K shares, compromising 2.57% of its total assets.
Legend Biotech Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 210 | -6.25% |
| 31 Dec, 23 | 224 | 5.16% |
| 30 Sep, 23 | 213 | 7.04% |
| 30 Jun, 23 | 199 | 18.45% |
| 31 Mar, 23 | 168 | -5.62% |
| 31 Dec, 22 | 178 | 6.59% |
| 30 Sep, 22 | 167 | 5.70% |
| 30 Jun, 22 | 158 | 8.22% |
| 31 Mar, 22 | 146 | 4.29% |
| 31 Dec, 21 | 140 | 55.56% |
| 30 Sep, 21 | 90 | - |
| 30 Jun, 21 | 90 | 26.76% |
| 31 Mar, 21 | 71 | 16.39% |
| 31 Dec, 20 | 61 | 22.00% |
| 30 Sep, 20 | 50 | -34.21% |
| 30 Jun, 20 | 76 | - |
As of 31 Mar 24, 210 institutions are holding Legend Biotech's shares, representing a decrease of -6.25% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 86,578,057 | 0.83% |
| 31 Dec, 23 | 85,866,686 | -0.09% |
| 30 Sep, 23 | 85,940,825 | 1.66% |
| 30 Jun, 23 | 84,537,184 | 24.29% |
| 31 Mar, 23 | 68,016,398 | 6.48% |
| 31 Dec, 22 | 63,874,963 | 0.12% |
| 30 Sep, 22 | 63,801,103 | 21.07% |
| 30 Jun, 22 | 52,698,237 | 3.35% |
| 31 Mar, 22 | 50,991,503 | 1.65% |
| 31 Dec, 21 | 50,162,073 | 28.63% |
| 30 Sep, 21 | 38,996,206 | 37.96% |
| 30 Jun, 21 | 28,266,998 | 7.14% |
| 31 Mar, 21 | 26,383,646 | 3.69% |
| 31 Dec, 20 | 25,444,631 | 3.94% |
| 30 Sep, 20 | 24,479,709 | -0.54% |
| 30 Jun, 20 | 24,613,275 | - |
Legend Biotech (LEGN) has 86.58M shares outstanding as of 31 Mar 24, up 0.83% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 49.17% | 8.09% |
| 31 Dec, 23 | 24.65% | 1.03% |
| 30 Sep, 23 | 48.96% | 1.87% |
| 30 Jun, 23 | 51.16% | 3.02% |
| 31 Mar, 23 | 41.16% | 2.55% |
| 31 Dec, 22 | 40.16% | 2.37% |
| 30 Sep, 22 | 41.19% | 3.56% |
| 30 Jun, 22 | 34.02% | 3.12% |
| 31 Mar, 22 | 33.04% | 2.82% |
| 31 Dec, 21 | 34.22% | 4.73% |
| 30 Sep, 21 | 26.90% | 6.46% |
| 30 Jun, 21 | 20.41% | 5.20% |
| 31 Mar, 21 | 19.82% | 5.36% |
| 31 Dec, 20 | 19.22% | 5.60% |
| 30 Sep, 20 | 18.52% | 3.55% |
| 30 Jun, 20 | 22.84% | - |
As of 31 Mar 24, Legend Biotech is held by 49.17% institutional shareholders, representing a 8.09% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 110 | -14.73% |
| 31 Dec, 23 | 129 | 35.79% |
| 30 Sep, 23 | 95 | -12.04% |
| 30 Jun, 23 | 108 | 18.68% |
| 31 Mar, 23 | 91 | 2.25% |
| 31 Dec, 22 | 89 | -15.24% |
| 30 Sep, 22 | 105 | 17.98% |
| 30 Jun, 22 | 89 | -2.20% |
| 31 Mar, 22 | 91 | -15.74% |
| 31 Dec, 21 | 108 | 107.69% |
| 30 Sep, 21 | 52 | - |
| 30 Jun, 21 | 52 | 33.33% |
| 31 Mar, 21 | 39 | 8.33% |
| 31 Dec, 20 | 36 | 44.00% |
| 30 Sep, 20 | 25 | -67.11% |
| 30 Jun, 20 | 76 | - |
110 institutional shareholders have increased their position in LEGN stock as of 31 Mar 24 compared to 129 in the previous quarter (a -14.73% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 64 | 8.47% |
| 31 Dec, 23 | 59 | -15.71% |
| 30 Sep, 23 | 70 | 7.69% |
| 30 Jun, 23 | 65 | 30.00% |
| 31 Mar, 23 | 50 | -13.79% |
| 31 Dec, 22 | 58 | 56.76% |
| 30 Sep, 22 | 37 | -24.49% |
| 30 Jun, 22 | 49 | 58.06% |
| 31 Mar, 22 | 31 | 47.62% |
| 31 Dec, 21 | 21 | 16.67% |
| 30 Sep, 21 | 18 | 5.88% |
| 30 Jun, 21 | 17 | 21.43% |
| 31 Mar, 21 | 14 | -12.50% |
| 31 Dec, 20 | 16 | -5.88% |
| 30 Sep, 20 | 17 | - |
| 30 Jun, 20 | - | - |
64 institutional shareholders have reduced their position in LEGN stock as of 31 Mar 24 compared to 59 in the previous quarter (a 8.47% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 210 | -6.25% | 86,578,057 | 0.83% | 49.17% | 8.09% | 110 | -14.73% | 64 | 8.47% |
| 31 Dec, 23 | 224 | 5.16% | 85,866,686 | -0.09% | 24.65% | 1.03% | 129 | 35.79% | 59 | -15.71% |
| 30 Sep, 23 | 213 | 7.04% | 85,940,825 | 1.66% | 48.96% | 1.87% | 95 | -12.04% | 70 | 7.69% |
| 30 Jun, 23 | 199 | 18.45% | 84,537,184 | 24.29% | 51.16% | 3.02% | 108 | 18.68% | 65 | 30.00% |
| 31 Mar, 23 | 168 | -5.62% | 68,016,398 | 6.48% | 41.16% | 2.55% | 91 | 2.25% | 50 | -13.79% |
| 31 Dec, 22 | 178 | 6.59% | 63,874,963 | 0.12% | 40.16% | 2.37% | 89 | -15.24% | 58 | 56.76% |
| 30 Sep, 22 | 167 | 5.70% | 63,801,103 | 21.07% | 41.19% | 3.56% | 105 | 17.98% | 37 | -24.49% |
| 30 Jun, 22 | 158 | 8.22% | 52,698,237 | 3.35% | 34.02% | 3.12% | 89 | -2.20% | 49 | 58.06% |
| 31 Mar, 22 | 146 | 4.29% | 50,991,503 | 1.65% | 33.04% | 2.82% | 91 | -15.74% | 31 | 47.62% |
| 31 Dec, 21 | 140 | 55.56% | 50,162,073 | 28.63% | 34.22% | 4.73% | 108 | 107.69% | 21 | 16.67% |
| 30 Sep, 21 | 90 | - | 38,996,206 | 37.96% | 26.90% | 6.46% | 52 | - | 18 | 5.88% |
| 30 Jun, 21 | 90 | 26.76% | 28,266,998 | 7.14% | 20.41% | 5.20% | 52 | 33.33% | 17 | 21.43% |
| 31 Mar, 21 | 71 | 16.39% | 26,383,646 | 3.69% | 19.82% | 5.36% | 39 | 8.33% | 14 | -12.50% |
| 31 Dec, 20 | 61 | 22.00% | 25,444,631 | 3.94% | 19.22% | 5.60% | 36 | 44.00% | 16 | -5.88% |
| 30 Sep, 20 | 50 | -34.21% | 24,479,709 | -0.54% | 18.52% | 3.55% | 25 | -67.11% | 17 | - |
| 30 Jun, 20 | 76 | - | 24,613,275 | - | 22.84% | - | 76 | - | - | - |
Legend Biotech Peer Ownership
| Ticker | Company |
|---|---|
| TERN | Terns Pharmaceuticals, Inc. |
| PLRX | Pliant Therapeutics, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| TVTX | Travere Therapeutics, Inc. |
| ETNB | 89bio, Inc. |
| PCVX | Vaxcyte, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| ALNY | Alnylam Pharmaceuticals, Inc. |
| ZLAB | Zai Lab Limited |
| DAWN | Day One Biopharmaceuticals, Inc. |
| AMLX | Amylyx Pharmaceuticals, Inc. |
| BPMC | Blueprint Medicines Corporation |
| MDGL | Madrigal Pharmaceuticals, Inc. |
| APLS | Apellis Pharmaceuticals, Inc. |
| ACLX | Arcellx, Inc. |
| KRTX | Karuna Therapeutics, Inc. |
| ASND | Ascendis Pharma A/S |
LEGN Ownership FAQ
Who Owns Legend Biotech?
Legend Biotech is owned by institutional shareholders (49.17%), insiders (1.32%), and public (49.51%). The largest institutional shareholder of Legend Biotech is FMR LLC (9.17% of total shares) and the top mutual fund owner is AMG FUNDS (2.57% of total shares).
Who are the major institutional shareholders of Legend Biotech?
Legend Biotech's major institutional shareholders are FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., and BLACKROCK INC.. The top five shareholders own together 25.74% of the company's share outstanding.
How many Legend Biotech shareholders are there?
As of Mar 2024, there are 210 institutional shareholders of Legend Biotech.
What percentage of Legend Biotech is owned by FMR LLC?
FMR LLC owns 16.15M shares of Legend Biotech, representing 9.17% of the company's total shares outstanding, valued at $905.69M (as of Mar 2024).
What percentage of Legend Biotech is owned by PRICE T ROWE ASSOCIATES INC /MD/?
As of Mar 2024, PRICE T ROWE ASSOCIATES INC /MD/ holds 10.95M shares of Legend Biotech (LEGN), compromising 6.22% of the company, valued at $614.14M.
What percentage of Legend Biotech is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P is the third largest holder of Legend Biotech. The company owns 6.86M of the company's shares outstanding (worth $384.84M).